Neuland Laboratories Ltd (NEULANDLAB) Management Interviews on Business TV
6 management interviews of Neuland Laboratories Ltd on Stocksigma, newest first.
- Is China Plus One A Big Tailwind For Neuland Labs? CEO Explains The Peptide Opportunity - CNBC-TV18 · 24 Sept 2026 · Saharsh Davuluri, CEO
- Neuland Labs Guides Upto 2x Asset Turnover For Hyderabad Facility: CEO Saharsh Davuluri - CNBC-TV18 · 24 Sept 2026 · Saharsh Davuluri, CEO
- Neuland Labs CEO On Peptide Facility Revenue, 15-20% Growth Guidance & Why Margins Won't Stay At 35% - CNBC-TV18 · 23 Sept 2026 · Saharsh Davuluri, Vice Chairman & MD
- Why Are Neuland Labs' Quarterly Numbers So Volatile? CEO Saharsh Davuluri Explains - CNBC-TV18 · 23 Sept 2026 · Saharsh Davuluri, CEO
- Growth Outlook | Will Focus On Manufacturing Peptide APIs For Innovators: Neuland Labs | CNBC TV18 - CNBC-TV18 · 23 Sept 2026 · Saharsh Davuluri, CEO & MD
- Inside Neuland Lab's Peptide Facility | Pursuing 15–20% Growth On An Annual Basis Is Reasonable: Co - CNBC-TV18 · 23 Sept 2026 · Saharsh Davuluri, CEO & MD
Interview Monitor: management interviews of all listed companies